Oriental Fortune Capital logo

Oriental Fortune Capital

Asia, Guangdong, China, Shenzhen

Description

Oriental Fortune Capital (OFC), also known as 东方富海, is a prominent venture capital firm based in Shenzhen, China, established in 2007. The firm has grown to become a significant player in the Chinese investment landscape, specializing in venture capital investment and fund management. OFC is recognized for its strategic focus on fostering innovation and growth within key emerging sectors across China.

The firm primarily targets early-growth to growth-stage companies, demonstrating a preference for businesses with proven models and significant scaling potential. OFC's investment thesis spans several high-growth industries, including TMT (Technology, Media, and Telecommunications), high-end manufacturing, new energy and environmental protection, healthcare, and consumer services. With assets under management exceeding 20 billion RMB, which translates to approximately $2.8 billion USD, Oriental Fortune Capital possesses substantial capital deployment capabilities, enabling it to participate in significant funding rounds.

Oriental Fortune Capital boasts an impressive track record, having made over 300 investments since its inception. The firm is particularly noted for its success in guiding portfolio companies towards public listings, with more than 70 of its invested companies achieving IPOs. This strong performance underscores OFC's expertise in identifying promising ventures and providing the strategic support necessary for their long-term success. The firm's approach emphasizes deep industry research, active post-investment management, and a commitment to creating sustainable value for its portfolio companies and limited partners.

The typical first check size for Oriental Fortune Capital generally ranges from $5 million for early-growth stage opportunities to approximately $40 million for more mature growth-stage companies, reflecting their capacity to lead or co-lead substantial funding rounds.

Investor Profile

Oriental Fortune Capital has backed more than 32 startups, with 7 new investments in the last 12 months alone. The firm has led 7 rounds, about 22% of its total and boasts 27 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Seed rounds (top funding stages).
  • Majority of deals are located in China, United States.
  • Strong thematic focus on Software, Manufacturing, Health Care.
  • Led 5 rounds in the past year.
  • Typical check size: $5M – $40M.

Stage Focus

  • Series B (28%)
  • Series A (28%)
  • Seed (19%)
  • Series C (16%)
  • Series Unknown (6%)
  • Series D (3%)

Country Focus

  • China (88%)
  • United States (13%)

Industry Focus

  • Software
  • Manufacturing
  • Health Care
  • Biotechnology
  • Information Technology
  • Artificial Intelligence (Ai)
  • Biopharma
  • Pharmaceutical
  • Internet
  • Big Data
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Oriental Fortune Capital frequently co-invest with?

Shunwei Capital
Asia, Beijing, China, Beijing
Co-Investments: 2
The Hina Group
North America, California, United States, San Francisco
Co-Investments: 2
Hillhouse Investment
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
Oceanpine Capital
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 2
Hillhouse Ventures
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
FTZ Fund
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Tuya
North America, California, United States, Santa Clara
Co-Investments: 3
Qiming Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Eight Roads Ventures
Europe, England, United Kingdom, London
Co-Investments: 3
Blue Lake Capital
Asia, Liaoning, China, Chaoyang
Co-Investments: 2

Which angels does Oriental Fortune Capital often collaborate with?

BG
Asia, China
Shared Deals: 1

What are some of recent deals done by Oriental Fortune Capital?

West Lake Intelligent Vision

Hangzhou, Zhejiang, China

West Lake Intelligent Vision is a developer of artificial intelligence and computational imaging fusion technology.

Advanced MaterialsArtificial Intelligence (AI)
SeedJul 14, 2025
Amount Raised: $6,975,154
X-ORIGIN

Shenzhen, Guangdong, China

X-ORIGIN-AI creates consumer-grade AI companion robots, redefining human-computer interaction with emotion-driven intelligence.

Artificial Intelligence (AI)Generative AIManufacturingRobotics
SeedApr 17, 2025
Amount Raised: $13,705,013
Qianxun Intelligence

Hangzhou, Zhejiang, China

Qianxun Intelligence is an intelligent technology developer that offers software development, intelligent robot research and development.

InternetSoftware
SeedMar 31, 2025
Amount Raised: $72,808,505
Gongjin Microelectronics

Minhang, Shanghai, China

Gongjin Microelectronics develops and manufactures electronic components and semiconductor solutions for various industries.

ElectronicsManufacturingSemiconductor
Series AMar 19, 2025
Amount Raised: $13,829,824
EVAS Intelligence

Nansha, Guangdong, China

EVAS Intelligence is an autonomous driving chip startup.

Autonomous VehiclesSemiconductor
Series AJan 20, 2025
Motoray

Shanghai, Shanghai, China

Motoray is a supplier of wire-controlled chassis motors.

Electric VehicleManufacturingSupply Chain Management
SeedDec 19, 2024
Aiator

Shenzhen, Guangdong, China

Aiator is an artificial intelligence product and technology solutions company

Artificial Intelligence (AI)BiotechnologyInformation TechnologyMachine Learning
Series ANov 6, 2024
Mufan Power

Minhang, Shanghai, China

Mufan Power provides technical consulting and engineering services for gas turbines, steam turbines and other turbomachinery.

ConsultingEnergy EfficiencyManufacturingService Industry
Series BSep 1, 2024
Amount Raised: $30,150,428
Blue Wave

Hangzhou, Zhejiang, China

Blue Wave is a producer of Industrial IoT and Internet of Vehicles chips.

Internet of ThingsManufacturing
SeedMay 4, 2023
Amount Raised: $14,478,695
Bangyao Biological

Minhang, Shanghai, China

Bangyao Biological is a gene-pharmaceutical company focusing on biological research activities and pharmaceutical development.

BiopharmaBiotechnologyPharmaceutical
Series BNov 14, 2022